HRGN (Harvard Apparatus Regenerative Technology) Tariff Resilience Score: 5/10 (As of Sep. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HRGN Harvard Apparatus Regenerative Technology Inc HRGN
13 GF Score
Price $1.52
! 2 Warning Signs
View Full Analysis

What is Harvard Apparatus Regenerative Technology Tariff Resilience Score?

Harvard Apparatus Regenerative Technology HRGN -3.80% 13 Tariff Resilience Score is 5 as of Sep. 01, 2026. GuruFocus rates HRGN with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 2,039 Consumer Packaged Goods companies, Harvard Apparatus Regenerative Technology ranks better than 94.26% on this metric.

Harvard Apparatus Regenerative Technology has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Harvard Apparatus Regenerative Technology has Harvard Apparatus faces moderate tariff risks due to its reliance on imported medical components. While it has some pricing power, the specialized nature of its products limits supplier flexibility. Previous tariffs have had a mixed impact on costs.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Harvard Apparatus Regenerative Technology might have Average Resilient.

Harvard Apparatus Regenerative Technology  (OTCPK:HRGN) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Harvard Apparatus Regenerative Technology Tariff Resilience Score Related Terms

HRGN vs STCB, BRLS, DTEAF: Tariff Resilience Score Comparison

For the Packaged Foods subindustry, Harvard Apparatus Regenerative Technology's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harvard Apparatus Regenerative Technology Tariff Resilience Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Harvard Apparatus Regenerative Technology's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Harvard Apparatus Regenerative Technology's Tariff Resilience Score falls into.


HRGN
13GF Score
Harvard Apparatus Regenerative Technology Inc HRGN
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Harvard Apparatus Regenerative Technology (HRGN) has a Tariff Resilience Score of 5 as of Sep. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Harvard Apparatus Regenerative Technology ranks #117 out of 2039 companies in the Consumer Packaged Goods industry, placing it in the top 5.7%.
Is Harvard Apparatus Regenerative Technology's Tariff Resilience Score too high?
Harvard Apparatus Regenerative Technology's current Tariff Resilience Score is 5. Based on the distribution chart, Harvard Apparatus Regenerative Technology ranks #117 out of 2039 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Harvard Apparatus Regenerative Technology has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Harvard Apparatus Regenerative Technology's Tariff Resilience Score compare to STCB and BRLS?
According to the Consumer Packaged Goods industry distribution chart, Harvard Apparatus Regenerative Technology ranks #117 out of 2039 companies for Tariff Resilience Score. This places Harvard Apparatus Regenerative Technology in the top 6% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Consumer Packaged Goods company?
A good Tariff Resilience Score depends on the Consumer Packaged Goods industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Harvard Apparatus Regenerative Technology's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Apparatus Regenerative Technology stock overvalued right now?
Harvard Apparatus Regenerative Technology (HRGN) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5. Harvard Apparatus Regenerative Technology's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Harvard Apparatus Regenerative Technology (HRGN), the current Tariff Resilience Score is 5 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Harvard Apparatus Regenerative Technology Business Description

Address 84 October Hill Road, Suite 11, Holliston, MA, USA, 01746
Harvard Apparatus Regenerative Technology is a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the gastrointestinal system and other organs that result from cancer, trauma, or birth defects. Its technology is based on a proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs. The Company has two operating and reportable segments: Regenerative Biotech, focused on the development of regenerative medicine treatments with operations currently in the United States, and Consumer Health Products relating to consumer health products with operations currently in Asia.
13GF Score

Get the complete analysis for HRGN

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.52
Price